Blocking IL-6/STAT3 axis suppressed IL-6 secretion from cancer-associated fibroblasts-cholangiocarcinoma interaction and enhanced gemcitabine sensitivity in cholangiocarcinoma cells. Here, STAT3 is linked to cancer.